ARHGEF12 and colonic neoplasm: In summary, both TSGs ARHGEF12 and APAF1 expression were downregulated in colon cancer and could be reactivated by CUR, and upregulated ARHGEF12 and APAF1 may be associated with favorable prognosis of patients.